New rinse aims to stop deadly heart device infections

NCT ID NCT07158502

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether TauroPace, an antimicrobial solution, can prevent infections in people getting implantable heart devices like pacemakers. Infections after these surgeries are rare but serious, sometimes fatal. The trial will compare TauroPace to standard saline rinsing in 1000 adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TauroPace (taurolidine solution)

What this could lead to

If it works, this could provide a simple, non-antibiotic way to prevent serious infections after heart device surgery.

What could go wrong

This is a single study with 1000 people. TauroPace may not reduce infections more than standard care, and rare allergic reactions are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIED-RELATED INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prosthesis-related infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••